Naobios collaborates with Sumagen to scale up HIV vaccine production
FRANCE – Naobios, a Contract Development and Manufacturing Organization (CDMO) specializing in...
Read MoreSelect Page
Oct 30, 2024
FRANCE – Naobios, a Contract Development and Manufacturing Organization (CDMO) specializing in...
Read MoreOct 15, 2024
FRANCE—Inventiva has announced a substantial financing package totaling US$410 million to develop...
Read MoreSep 9, 2024
FRANCE—German life science company Evotec SE and X-Chem, a leader in DNA-encoded library (DEL)...
Read MoreSep 4, 2024
FRANCE—The European Medicines Agency (EMA) has granted SeaBeLife, a biotechnology company focused...
Read MoreAug 6, 2024
FRANCE—Sanofi, the French pharmaceutical giant, has announced a US$1.4 billion (1.3 billion euros)...
Read MoreJul 1, 2024
FRANCE—The European Commission (EC) has authorized Pierre Fabre Laboratories to market OBGEMSA™...
Read MoreJun 6, 2024
FRANCE – Sanofi’s anti-CD38 monoclonal antibody Sarclisa has demonstrated promising...
Read MoreMay 31, 2024
FRANCE – French pharmacists staged their first nationwide strike in a decade to protest...
Read MoreFeb 6, 2024
FRANCE – Global healthcare and pharmaceutical company Sanofi has appointed François-Xavier...
Read MoreJan 11, 2024
CANADA – bioMérieux, a global pioneer in vitro diagnostics, has announced the purchase of LUMED, a...
Read More